White Deer Partners (WDP) uses quantitative business analytics to drive high-quality decisions in the biopharmaceutical oil/gas, and technology industries.  By employing the rigorous and proven frameworks of decision analysis, we help our clients understand the underlying drivers of value and risk, resulting in more effective decisions to maximize shareholder value.  We are experts in decision process management, expert facilitation and assessment, user-friendly modeling, and bringing cross-functional teams to consensus through fact-based analyses.  Our primary service areas are:

 

Strategic Product Planning – developing long-term clinical plans including 

• Label strategy – therapeutic areas, indications, geographic focus

• Clinical trial design – endpoints, controls, other design factors 

• Marketing strategy – communications strategy, sales strategy, pricing strategy

• Manufacturing strategy – ROI analyses of build or buy options

 

Forecasting and Valuation – using probabilistic revenue forecasts and discounted cash-flow modeling, WDP can help clients determine the value of a given asset and the key determinants of that value

 

Portfolio Management – using prioritization processes and tools to analyze a set of investment opportunities, WDP helps clients understand the risk-benefit trade-offs of different portfolios

 

Capital Investments – using long-term modeling, real options thinking, contingency planning, and advanced scenario modeling to understand and manage capital expenditures

 

Business Development – understanding the risks and potential of external opportunities, accounting for key uncertainties in a structured approach

 

Internal Capability Development – through customized courses, WDP offers training for executives and team members to understand how the choices and strategies we make shape our lives and organizations